Kenward-Roger ≥ Satterthwaite [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-11-08 20:57  – Posting: # 20771
Views: 3,889

Hi PharmCat,

» I thought that Kenward-Roger provide the same DF as Satterthwaite's for one-dimension effects, so as CI for coefficient is one-dimension hypothesis DF should be the same, as it describes in reference paper, may be SAS make any corrections, I don't know...

Try this one:

library(replicateBE)
ds  <- substr(grep("rds", unname(unlist(data(package = "replicateBE"))),
                   value = TRUE), start = 1, stop = 5)
res <- data.frame(rds = 1:length(ds), df.Satt = NA, df.KR = NA)
for (j in seq_along(ds)) {
  res$df.Satt[j] <- method.B(option = 1, print = FALSE, details = TRUE,
                             data = eval(parse(text = ds[j])))$DF
  res$df.KR[j]   <- method.B(option = 3, print = FALSE, details = TRUE,
                             data = eval(parse(text = ds[j])))$DF
}
res[, 2:3] <- signif(res[, 2:3], 5)
print(res, row.names = FALSE)


The EMA’s Method B evaluated by lmer() of package lmerTest. Kenward-Roger’s degrees of freedom ≥ Satterthwaite’s.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,811 posts in 4,355 threads, 1,448 registered users;
online 12 (1 registered, 11 guests [including 7 identified bots]).
Forum time: 11:39 CEST (Europe/Vienna)

One of the symptoms of an approaching nervous breakdown
is the belief that one’s work is terribly important.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5